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Morphological diflerentiation of N2A ncuroblastoma cells is associated with an altered splicing of the gene of the microtubule-associated protein, 
tau. Two populations of RNA (coding for tau proteins containing three or four tubulin.binding motifs) are present in a similar proportion in 
undifferentiated neuroblastoma cells while in differentiated cells the proportion is changed in favour of that population coding for tau protein 
containing four tubulin-binding motifs. An increase in a high molecular weight au isoforms correlates with the increase in the RNA population 
coding for four tubulin-binding motifs, A possible consequence ofexpressing a higher proportion of the tau protein containing four tubulinmbinding 
motifs could lx an increase in microtubule stability of differentiated neuroblastoma cells. 
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1. INTRODUCTION 
The extension of neutral processes is an event de- 
pendent on microtubule assembly [1,2]. Kirschner and 
Mitchison suggested that such extension takes place due 
to stabilization of a microtubule population upon the 
reception of an external signal [3]. Thus, the molecules 
which can stabilize microtubules have been studied. 
These molecules have been characterized in the same 
way as the proteins that associate to brain microtubules 
(MAPS) 141. Tau, one of these MAPS [5,6], has been 
specifically involved in the stabilization of microtubules 
in vivo [7] and in neurite xtension [8]. Brain tau protein 
is a family of related peptides [6] which are translated 
from different mRNAs, generated by alternative splic- 
ing of a precursor RNA transcripted from a single gene 
[9-l 13. Brain tau peptides can be divided in two classes, 
one containing three repeated sequences involved in the 
binding of tau to tubulin, and a second containing four 
of those sequences [9,12-151. The first class is mainly 
present in early developmental stages, while the second 
is mainly expressed in mature brain [12-141. It has been 
suggested that tau containing four tubulin-binding 
motifs associates to (and stabilizes) microtubules better 
than tau containing three motifs [16]. 
Neuroblastoma cells have been used as a model to 
study the extension of neural processes. Under certain 
conditions, such as the removal of serum from culture 
medium, neuroblastoma cells extend neurites 1171. It has 
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been suggested, that microtubule proteins play a role in 
such neurite extension [1,2]. During this event a net 
microtubule assembly takes place, probably depedent, 
at least in part, on the modification (phosphorylation) 
of microtubule proteins [18-211 like tubulin and 
MAP,B. However, a possible role for other proteins in 
increasing the amount of microtubule polymer can not 
be ruled out. One of these proteins could be tau, as 
previously indicated, The presence of tau-related 
proteins in neuroblastoma cells has been described [22] 
although some of their characteristics differ from those 
of brain tau peptidcs. In neuroblastoma cells peptides 
with a similar electrophoretic mobility to tau were ob- 
served [22,23] together with a tau-related protein with 
a higher apparent molecular weight of 120 kDa, mainly 
present in differentiated cells [22]. A similar protein was 
found in pheochromocytoma (PC 12) cells [22,24]. This 
protein appears to be specific for cells from peripheral 
nervous systems [25]. 
In this work we have analyzed the role of tau-related 
proteins during the morphological differentiation 
(neurite extension) of neuroblastoma cells, Our results 
indicate that an increase inthe expression of tau-related 
peptides containing four tubulin-binding motifs ac- 
companies differentiation of neuroblastoma cells. 
2. MATERIALS AND METHODS 
2. I. Materich 
Monoclonal tau antibodies, 7.5i and 133, have been described elsa 
where [26,27]. Polyclonal tau antibodies have been also described [271. 
Oligonucleotides spanning tau cDNA position 573-592 (RI). 942- 
966 (R2) and 1133-l 152 (Ctj, were synihctbcd usin& a DNA synthe- 
tizer (Applied Biosystcms Inc.). Restriction r&eases Hind111 and 
BnuI were purchased from Boehringer-Mannheim. 
Published by Elsevier Science Publisircrs B. V. 
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2.2. Gel! cuhirc 3. RESULTS 
N2A mouse ncuroblastoma cells were grown in Dulbccco’s 
modiflcd Eagle’s medium (DMEM) supplemented with 10% fetal 
bovine serum and induced to differentiate by transfer to DMEM 
without serum. Phosphate labclling was performed for 20 h with 1 
mCi/ml a2P (Amersham) as previously described [20]. [“S]Methionine 
labelling was done for 16 h with 0.5 Cilml (Amersham), 
3.1. Localization of tuu related proteins in neuto- 
blastom ceils 
2.3. ~nnl~n~mofluorcscence analyses 
Cdl cultures were grown. fixed and processed as previously indim 
cated [17,28]. The samples wcrc examined using a confocal fluores. 
cence microscope. 
2,4. RNA isolution and cDN.4 spiresis 
RNA was prepared by the method of Han et al, [29]. cDNA synthe- 
sis was carried out by doing a further addition of AMV reverse 
transcriptase (5 U&g) and 200 mM of each of the four deoxynu- 
clcotide triphosphates, After synthesis the RNA was degraded by 
RNase A. 
Oligonucleotides Rl and Ct or Rl and R2 were mixed with total 
cDNA, For PCR amplification the cDNA products were mixed with 
1 ,uM of the oligonuclcotidcs used. Two pair of primcra were used for 
each analysis, (see Fig. 4), Rl and Ct, and Rl and R2. The obtained 
cDNA was characterized by gel clectrophoresis, Southern blot [30] 
and by partial digestion with endonucleasc restriction enzymes. 
N2A neuroblastoma cells were cultured in the pres- 
ence (undifferentiated cells) or in the absence (differ- 
entiated cells) of serum [20] and fixed with cold meth- 
anol for immunofluorescence analyses. The analyses 
were carried out using different antibodies againt tau. 
An example, using one of them, is indicated in Fig. 1, 
in which a morphologically differentiated (i.e. a cell with 
extended processes) is shown together with an undif- 
ferentiated, spherical, cell. The antigen reacting with tau 
antibody is localized to cytoskeletal structures identified 
as microtubules, since these structures are not present 
in colcemide-treated cells [not shown). Also, as indi- 
cated, the presence of tau-related protein is evident in 
the extended neuronal processes in morphologically dif- 
ferentiated cells. 
3.2. Characterization of tau related proteins in neuro- 
2.5. Protein prepnfariou 
blustorna cells 
Total protein or heat-resistant prolein from neuroblastoma cells 
was obtained by homogenization of the cells with a teflon-glass ho- 
mogenizer and centrifugation of the cell homogenates in a Beckman 
airfuge (2 min at maximum speed). The heat-resistant fraction was 
obtained upon boiling of the sample for 5 min in the conditions 
described by Herzog and Weber [31]. The perchloric-soluble, glycerol- 
insoluble protein was isolated as described by Lindwall and Cole [32]. 
Proteins were characterized by elcctrophoresis on polyacrylamidc 
gels [33] and identified by Western blot [34]. 
To isolate tau-related proteins from undifferentiated 
and differentiated neuroblastoma cells the protocol of 
Lindwall and Cole [32] for brain tau was followed. The 
method is based in the solubility of tau in perchloric 
acid and its precipitation by glycerol 1321. Fig. 2 shows 
the polypeptide pattern of the protein fraction which is 
soluble in perchloric acid and insoluble in glycerol, ob- 
tained from undifferentiated or differentiated neuro- 
Fig. Immunofluorcxence staining pattern of neuroblastoma cells incubated with a polyclonal antibody to tau. Morphologically, two 1 
cells cm be observed, undifferentiated (spherical shape) and difkrentiatcd (asymmetric shape). 
11 
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Fig. 2. Characterization of perchloric-soluble, glycerol-insoluble, 
proteins from ncuroblastoma cells. N2A neuroblastoma cells were 
grown in the prcsenee of 05 mCi/ml of [“Slmethionine and in the 
presence (U) or the absence (D) of serum. The cells were homogenized 
as indicated in section 2 and 2.5% (v/v) pcrchloric acid was added. The 
soluble fraction after cenvifugation (15,000 x g for I5 min) was mixed 
with 25% glycerol and the pelleted protein, after centrifugation (1.500 
x g for I5 min), was characterized by electrophoresis. 
blastoma cells cultured in the presence of [35S]mcthi- 
onine. 
A major protein with an apparent molecular weight 
of 64 kDa was found. Additionally, and only for differ- 
entiated cells, a 100 kDa protein was observed. In some 
cases minor peptides, with a molecular weight below 45 
kDa were observed for differentiated and undiffer- 
entiated cells (data not shown). Both 100 and 64 kDa 
proteins were heat resistant, a property similar to that 
of brain tau [31]. By Western blot analyses, using a 
whole cell protein extract, it was found that the 64 kDa 
protein reacts against an anti-tau antibody (7.51) which 
recognizes a region close to the carboxy-terminus of 
brain tau [37] (Fig. 3), and with a polyclonal antibody 
;igainst mu, raised against a pcptide included in the 
second tubulin-binding motif [9] of brain tau (not 
shown). Additionally, in the case of differentiated neu- 
roblastoma cells, the 100 kDa protein reacted with anti- 
tau antibodies. However, no reaction was found for 
neuroblastoma tau-related proteins, with an antibody 
(133) that recognizes an epitope located at the amino- 
terminus of brain tau [37]. 
3.3. Ctlarrrcferiznfion of fau RNA transcribed on neu- 
roblastoma cells 
The function of tau in microtubule stabilization prob- 
ably depends on its interaction with tubulin, which itself 
depends on the number of tubulin-binding motifs, being 
greater for tau containing four motifs than for tau co+ 
taining three motifs [163. Thus, we have tested if there 
is a change in the population of tau containing three or 
four tubulin-binding motifs during neuroblastoma cell 
100 - 
68. 
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Fig. 3. Electrophorcsis and immunoblot analysis of total protein from 
undifferentiated and differentiated neuroblustoma cells. Total protein 
from undifferentiated (U) and differentiated (D) N2A cells was frac- 
tionated by gel cleetrophoresis, transfcred to nitrocellulosc and tested 
with anti-mu monoclonnl antibody, 7.51. 
differentiation. Since we do not have an antibody which 
specifically recognizes the extra tubulin-binding motif 
we have done the test by analyzing tau RNA transcribed 
in undifferentiated and differentiated neuroblastoma 
cells. 
Total RNA was prepared from undifferentiated and 
differentiated cells and used, together with the oligonu- 
cleotides Rl and R2 or Rl and Ct (see section 2.4. and 
Fig. 4), for cDNA synthesis. We have used these oligo- 
nucleotides ince, as previously indicated, we found that 
neuroblastoma tau-related proteins contain sequences 
related to those of brain tau present at the tubulin- 
binding motif and at the carboxy-terminus, but do not 
contain some sequences located at the amino-terminus 
of brain tau. PCR amplification was done with the indi- 
vidual cDNA products, and the amplified cDNA from 
undifferentiated and differentiated cells was charac- 
terized. Three types of analyses wert done that are 
shown in Fig. 5. Fig. SA shows the si& distribution of 
amplified cDNA from undifferentiated and differ- 
entiated cells synthetized in the presence of Rl and Ct 
oligonucleotides, while Fig. 5B shows those synthetized 
in the presence of Rl and R2. In both cases, two prom- 
inent cDNA bands with a difference in size of 100 base 
pairs were found. For undifferentiated cells, a similar 
12 
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Fig. 4. Schematic map of tau cDNA. The box shows the tubulin- 
binding region. Arrows indicate the positions and orientation of where 
the synthetic oligonuclcotides (used to specifically prime cDNA syn- 
thesis) bind. The sequences for the oligonucleotides Rl, R2 and Ct arc 
indicated in section 2. 
proportion of each band was found, while for differ- 
entiated cells a larger proportion was observed for the 
slower migrating band. 
The previous result is compatible with the presence 
of two cDNA populations; one containing three tu- 
bulin-binding regions (the faster migrating band), and 
the other containing an extra fourth tubulin-binding 
motif (the slower migrating band) [9,12-151. MU D 
A second type of analysis was the Southern blot to 
show that indeed the previous cDNA were tau cDNAs. 
Fig. SC shows that it is indeed the case, since both bands 
reacted with tau cDNA. 
c 
A third type of analysis, to look for the presence of 
an extra tubulin-binding motif in the slower migrating 
band, was to test the restriction map of both cDNAs 
upon cleavage with .%a1 restriction endonuclease, 
which should cleave the larger but not the smaller 
cDNA fragment according to the nuclcotide sequence 
for cDNA tau containing three and four tubulin-bind- 
ing motifs [13,14], and with HindHI, which should yield 
similar restriction maps. Fig. SD shows that this ap- 
pears to be the case, since a similar map was found for 
both fragments after Hind111 incubation while dif- 
ferences were observed upon treatment with SmaI en- 
donuclease. 
. 
. 
0 
4. DISCUSSION u D HCSH CSH 
During neuroblastoma cell differentiation a net in- 
crease in the amount of microtubule polymer has been 
extensively described [18,20,21]. This increase has been 
correlated with an increase in the phosphorylation of 
beta tubulin subunit and MAP,B [EL211, but other 
factors, like tau factor, could be involved in the change 
of polymer amount. The presence of tau-related protein 
in neuroblastoma cells has been observed by immuno-a 
fluorescence, and their characterization based on their 
solubility in perchloric acid, precipitation with glycerol, 
heat resistance and reaction with anti-tau antibodies 
indicate common features between these proteins and 
brain tau. Tau has been involved in microtubule sta- 
bilization [7] and since that stabilization may be greater 
for tau isoforms containing four tubulin-binding motifs 
that for those isoforms containing three motifs [16] we 
have tested whether, during neuroblastoma differentia- 
tion, there is a change in the proportion of one or the 
Pig. 5. Characterization of tau cDNAs. Total RNA from undiffer- 
entiated (U) and differentiated (D) cells were mixed with oligonu- 
cleotides RI and CT (A) or with oligonuclcotides Rl and R2 (B), for 
cDNA synthesis. PCR amplification was done with the individual 
cDNA products in the presence ofthe respective oligcmsleotides. Tbc 
amplified cDNAs wcrc characterized bygel clectrophoresis. M shows 
the DNA fragments of 123,24B, 369.492.615, . . . basepairs used as 
eletrophoretic markers. (C) Southern blot analysis of the cDNAs as 
indicated in section 2. It shows that tau DNA binds to both cDNA 
fragments present in a larger amount in (A) and (B). (D) Tnu cDNAs 
isolated in (A) and (B) were digested with restriction ucleases H/rrdllI 
(H), Bnnl (S) or undigcstcd (C) and the resulting fragments were 
characterized by gel clectrophoresis. Onthe left of the figure are shown 
the same markers used in (A) and (l3). 
other isoform class. To do that, tau RNA transcribed 
in undifferentiated ordifferentiated neuroblastoma cells 
was characterized. 
Our results have shown that in undiKereniiaied 
mouse N2A neuroblastoma cells two RNA popula- 
tions, coding for the tau region containing the tubulin- 
13 
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binding motifs, are present. One population will be 
translated into a protei.. ‘n that contains three tubulin- 
binding motifs, while the other has an extra motif. A 
similar proportion of each population was found for 
RNA populations in undifferentiated cells. However, in 
morphologically differentiated cells, essentially only the 
population containing four motifs was observed. This 
result suggests that the 100 kDa tau-related proteins 
present only in differentiated cells may contain four 
tubulin-binding motifs, like the majority of the other 
tau-related proteins present in differentiated cells. A 
possible consequence of the increase of tau-related 
proteins containing four tubulin motifs will be a higher 
stabilization of cell microtubules that could also result 
in a decrease in their depolymerization, and if no 
changes in polymerization take place the consequence 
will be a net microtubule polymerization, 
During differentiation of N2A neuroblastoma cells a 
change in the phosphorylation of two microtubule 
proteins, MAP,B and tubulin, without a dramatic 
change in their mass, has been described [l&20,21]. For 
tau-related proteins no main change for the mass of the 
64 kDa protein was observed although this protein be- 
comes modified by phosphorylation (J.D.N., prelimi- 
nary observations), while an increase in the synthesis of 
the 100 kDa protein (but not in its phosphorylation; 
I.C., unpublished results) was found. Thus, during neu- 
roblastoma differentiation the main change observed 
for tau-related proteins was the increase in those 
isoforms containing four tubulin-binding motifs, after 
selection of a preferential way for alternative RNA 
splicing. A possible exploration for the selection of this 
alternative RNA splicing may be the induction of spc- 
cific factors upon serum withdrawal in cultured neuro- 
blastoma cells. These factors may overcome a possible 
steric interference between splice sites that could block 
the splicing of the exon containing the fourth tubulin- 
binding motif in a way similar to that described for the 
splicing block of a short c-src neuron-specific exon in 
non-neural cells [SS]. Other cases for the selection of an 
alternative way of RNA splicing have been i dicated for 
other RNAs upon neuroblastoma differentiation, such 
as that of/?/A4 amyloid RNA [36] that is translated into 
a protein that has been related, like tau protein, some 
features in Alzheimer’s disease. 
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